These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 16548370)
21. [A randomized, double-blind, placebo-controlled study of Cerebrolysin safety and efficacy in the treatment of acute ischemic stroke]. Skvortsova VI; Stakhovskaia LV; Gubskiĭ LV; Shamalov NA; Tikhonova IV; Smychkov AS Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 11):51-5. PubMed ID: 15559222 [TBL] [Abstract][Full Text] [Related]
22. Linguistic and cognitive functioning and autism symptoms in young children with fragile X syndrome. Philofsky A; Hepburn SL; Hayes A; Hagerman R; Rogers SJ Am J Ment Retard; 2004 May; 109(3):208-18. PubMed ID: 15072521 [TBL] [Abstract][Full Text] [Related]
23. [Pharmacological approaches to the therapy of Alzheimer's disease]. Gavrilova SI Vestn Ross Akad Med Nauk; 2006; (9-10):30-4. PubMed ID: 17111921 [TBL] [Abstract][Full Text] [Related]
24. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study. Aupperle PM; Koumaras B; Chen M; Rabinowicz A; Mirski D Curr Med Res Opin; 2004 Oct; 20(10):1605-12. PubMed ID: 15462693 [TBL] [Abstract][Full Text] [Related]
25. Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months. Research Units on Pediatric Psychopharmacology Autism Network Am J Psychiatry; 2005 Jul; 162(7):1361-9. PubMed ID: 15994720 [TBL] [Abstract][Full Text] [Related]
26. [Cerebrolysin Treatment Reduces the Risk of Mild Cognitive Decline to Dementia in 1st-Degree Relatives of Alzheimer's Patients: A Prospective Comparative Study]. Selezneva ND; Gavrilova SI Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(8):90-97. PubMed ID: 37655416 [TBL] [Abstract][Full Text] [Related]
28. Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities. Valicenti-McDermott MR; Demb H J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):549-60. PubMed ID: 17069544 [TBL] [Abstract][Full Text] [Related]
29. [Monitoring of neurotrophic factors and cognitive function in patients with traumatic brain injury]. Karakulova YV; Selyanina NV Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):34-37. PubMed ID: 29171486 [TBL] [Abstract][Full Text] [Related]
30. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial. Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403 [TBL] [Abstract][Full Text] [Related]
31. [Clinical observation of aripiprazole in the treatment of autism]. Xie Q; Tang J; Xu Y; Zeng HL Zhongguo Dang Dai Er Ke Za Zhi; 2013 Apr; 15(4):294-7. PubMed ID: 23607954 [TBL] [Abstract][Full Text] [Related]
32. Cognitive and behavioral complications of frontal lobe epilepsy in children: a review of the literature. Braakman HM; Vaessen MJ; Hofman PA; Debeij-van Hall MH; Backes WH; Vles JS; Aldenkamp AP Epilepsia; 2011 May; 52(5):849-56. PubMed ID: 21480882 [TBL] [Abstract][Full Text] [Related]
33. [The efficacy of combination therapy with mexidol and cerebrolysin in chronic cerebral ischemia]. Berezhnaya SV; Yakupov EZ; Zaharov YA Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(5):23-27. PubMed ID: 27240176 [TBL] [Abstract][Full Text] [Related]
34. Epilepsia, epileptiform abnormalities, non-right-handedness, hypotonia and severe decreased IQ are associated with language impairment in autism. Oslejskova H; Dusek L; Makovska Z; Rektor I Epileptic Disord; 2007 Dec; 9 Suppl 1():S9-18. PubMed ID: 18319196 [TBL] [Abstract][Full Text] [Related]
35. [Developmental dysphasia in children: perspectives of neurotrophic therapy]. Zavadenko NN; Kozlova EV Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5 Pt 2):43-7. PubMed ID: 23739513 [TBL] [Abstract][Full Text] [Related]
36. [Treatment of behavioral disorders by risperidone in children with autism]. Wei BY; Huang F; Qin XT; Liang QQ Zhongguo Dang Dai Er Ke Za Zhi; 2011 Mar; 13(3):216-8. PubMed ID: 21426640 [TBL] [Abstract][Full Text] [Related]
37. Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study. Troost PW; Lahuis BE; Steenhuis MP; Ketelaars CE; Buitelaar JK; van Engeland H; Scahill L; Minderaa RB; Hoekstra PJ J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1137-44. PubMed ID: 16239862 [TBL] [Abstract][Full Text] [Related]
38. Cerebrolysin therapy in Rett syndrome: clinical and EEG mapping study. Gorbachevskaya N; Bashina V; Gratchev V; Iznak A Brain Dev; 2001 Dec; 23 Suppl 1():S90-3. PubMed ID: 11738849 [TBL] [Abstract][Full Text] [Related]
39. [Current approaches to the problem of autism in childhood]. Bashina VM Vestn Ross Akad Med Nauk; 2001; (7):7-13. PubMed ID: 11523431 [TBL] [Abstract][Full Text] [Related]
40. [Asthenic disorders and cognitive dysfunction in patients with tension headache]. Chutko LS; Surushkina SIu; Rozhkova AV; Iakovenko EA; Bykova IuL; Nikishina IS Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5):31-5. PubMed ID: 23739500 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]